Check out our most popular compounded medications! Get Started
Aminolevulinic Acid HCl 5% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This design allows for easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients. The gel-like consistency of the formulation enhances the delivery of Aminolevulinic Acid HCl, a potent agent used in the treatment of various disease states. The formulation is primarily used in the management and treatment of conditions such as actinic keratosis, a precancerous skin condition, and other dermatological conditions that respond to photodynamic therapy.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Aminolevulinic Acid HCl 5% Topical Gel is a specially formulated semisolid medication designed for easy and precise application on the skin. The gel is dispensed through a pump mechanism, ensuring a controlled dosage and targeted treatment. This formulation is primarily used for the treatment of certain skin conditions, leveraging the active ingredient's properties to achieve therapeutic effects.
The active ingredient, Aminolevulinic Acid HCl, is a photosensitizing agent. When applied to the skin, it is metabolized by cells to form a compound called Protoporphyrin IX. This compound, when exposed to certain types of light, produces a form of oxygen that kills the cells. This mechanism of action is particularly useful in treating skin conditions such as actinic keratosis (a precancerous skin condition), and certain types of skin cancer.
Patients using this formulation should be aware that the treated area will become photosensitive for a period of time after application. It is crucial to avoid exposure to sunlight or bright indoor light during this period. Protective clothing and sunglasses may be necessary to protect the treated area. Side effects may include redness, swelling, and a burning sensation at the application site. If these side effects persist or worsen, contact your healthcare provider immediately.
Prescribers should note that this formulation is not suitable for all patients. It should not be used by patients with known hypersensitivity to any of the ingredients, or by patients with porphyria or other diseases that may be exacerbated by exposure to light. The safety and effectiveness of this formulation in pediatric patients have not been established. As with all medications, the potential benefits of treatment should be weighed against the potential risks.
If you have any questions about Aminolevulinic Acid HCl 5% Topical Gel, or if you would like more information about this or any other compounding formulation, please don't hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to help.
Aminolevulinic Acid HCl 5% Topical Gel is a photosensitizing agent used in photodynamic therapy (PDT). It is primarily used to treat actinic keratosis (AK), a skin condition that can lead to skin cancer if left untreated. The gel is applied to the affected area and then exposed to a specific type of light. This causes a reaction that destroys the abnormal skin cells.
It is important to inform your healthcare provider of all medications, supplements, and skin products you are currently using before starting treatment.
Photosensitizing drugs: Concurrent use of other photosensitizing drugs such as tetracyclines, thiazides, sulfonylureas, phenothiazines, sulphonamides, quinolones, and certain antifungals may increase the photosensitivity reaction of Aminolevulinic Acid HCl 5% Topical Gel. This could lead to an increased risk of skin redness, swelling, and other side effects.
Topical skin products: The use of certain skin products, particularly those containing alcohol, astringents, spices, lime, or other irritants, may cause additional skin irritation when used with Aminolevulinic Acid HCl 5% Topical Gel. It is recommended to avoid these products while undergoing treatment.
Antioxidants: Certain antioxidants, such as vitamins C and E, may interfere with the effectiveness of Aminolevulinic Acid HCl 5% Topical Gel. These substances can neutralize the reactive oxygen species generated during PDT, reducing the treatment's effectiveness.
It is also important to avoid exposure to sunlight or bright indoor light for at least 48 hours after application of the gel, as this can cause a reaction leading to severe sunburn. Protective clothing and sunglasses should be worn if exposure to light cannot be avoided.
Always inform your healthcare provider if you experience any unusual or severe side effects while using Aminolevulinic Acid HCl 5% Topical Gel. This includes severe skin redness, blistering, or swelling, as well as any signs of an allergic reaction such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.
If you have any questions about Aminolevulinic Acid HCl 5% Topical Gel, its interactions, or its use in treating actinic keratosis, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you.
Aminolevulinic Acid HCl 5% Topical Gel is a unique formulation that works by inducing photosensitivity in the skin. Aminolevulinic acid (ALA) is a naturally occurring substance in the body that is converted into a chemical called protoporphyrin IX (PpIX). PpIX accumulates in the skin cells and makes them more sensitive to certain types of light. When exposed to a specific wavelength of light, the PpIX is activated and causes damage to the targeted cells, which then die and are replaced by healthy cells.
The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin. This is particularly beneficial for targeted treatment, as it ensures that the active ingredient is applied directly to the affected area. The gel-like consistency of the formulation also aids in the absorption of the active ingredient into the skin.
Aminolevulinic Acid HCl 5% Topical Gel is used to treat a variety of skin conditions. It is commonly used in photodynamic therapy (PDT) for the treatment of actinic keratosis, a precancerous skin condition caused by sun exposure. The gel is applied to the skin and then the area is exposed to a specific type of light. This activates the PpIX, which then destroys the abnormal cells.
It is also used in the treatment of acne, as it can help to reduce the size and severity of acne lesions. The gel is applied to the skin and then the area is exposed to a specific type of light. This activates the PpIX, which then destroys the bacteria that cause acne.
For both patients and prescribers, it's important to note that the use of Aminolevulinic Acid HCl 5% Topical Gel should be followed by avoidance of sun exposure and bright indoor light for at least 48 hours. This is because the skin will be more sensitive to light and may burn more easily. Also, the gel should not be applied to the eyes or mucous membranes, as it can cause irritation.
If you have any questions about Aminolevulinic Acid HCl 5% Topical Gel, please don't hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to help.
Aminolevulinic Acid HCl 5% Topical Gel is a semisolid formulation used for application on the skin. The active ingredient, Aminolevulinic Acid HCl, is suspended in a gel-like consistency for targeted treatment.
This product comes with a pump mechanism. This design facilitates easy and precise application of the gel on the skin.
The gel-like consistency lets the product adhere better to your skin, allowing for improved absorption of the active ingredient, Aminolevulinic Acid HCl.
The 5% indicates the concentration of the active ingredient - in this case, Aminolevulinic Acid HCl. This means that in every 100g of the gel, there is 5g of Aminolevulinic Acid HCl.
Apply the gel on the targeted area of your skin using the pump mechanism. Always follow the instructions provided by your health care provider or refer to the package insert for detailed application instructions.
Aminolevulinic Acid HCl 5% Topical Gel should only be applied on the area recommended by your doctor or health care provider. Avoid applying on broken skin, near the eyes, nose, or mouth.
Before mixing it with other skincare products, please consult with your healthcare provider. Some products may interfere with the effectiveness of Aminolevulinic Acid HCl 5% Topical Gel or cause skin irritation.
If you experience severe skin irritation or any unusual effects after applying the product, stop using it immediately and contact your healthcare provider. Mild skin irritation is common and should subside in a few days but if it doesn't, reach out to your healthcare provider.
This product should be stored in a cool and dry place, out of reach of children. Do not store it in direct sunlight or at high temperatures.
Over time, changes in color or consistency can indicate degradation of the product. If you notice such changes, stop using the product and contact your pharmacy.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
